Phase 1b/Study of VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Phase of Trial: Phase I/II
Latest Information Update: 24 Nov 2017
At a glance
- Drugs Avelumab (Primary) ; VX 15 (Primary)
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- Acronyms CLASSICAL-Lung
- Sponsors Vaccinex
- 26 Oct 2017 According to a Vaccinex media release, the first patient has been dosed in this trial.
- 11 Oct 2017 Status changed from not yet recruiting to recruiting.
- 28 Aug 2017 Status changed from planning to not yet recruiting.